BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou L, Zou M, Xu Y, Lin P, Lei C, Xia X. Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics. Front Oncol 2022;12:864301. [PMID: 35664731 DOI: 10.3389/fonc.2022.864301] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gong X, Chi H, Strohmer DF, Teichmann AT, Xia Z, Wang Q. Exosomes: A potential tool for immunotherapy of ovarian cancer. Front Immunol 2023;13. [DOI: 10.3389/fimmu.2022.1089410] [Reference Citation Analysis]
2 Katopodi T, Petanidis S, Tsavlis D, Anestakis D, Charalampidis C, Chatziprodromidou I, Eskitzis P, Zarogoulidis P, Kosmidis C, Matthaios D, Porpodis K. Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy. Front Oncol 2022;12:1042125. [DOI: 10.3389/fonc.2022.1042125] [Reference Citation Analysis]
3 Persano F, Leporatti S. Nano-Clays for Cancer Therapy: State-of-the Art and Future Perspectives. JPM 2022;12:1736. [DOI: 10.3390/jpm12101736] [Reference Citation Analysis]